Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00045630 · FLOW

Participant flow

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium · Source last updated 2013-05-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Patients receive 3 cycles (1 cycle = 21 days) of neoadjuvant chemotherapy (800 mg/m\^2 of gemcitabine IV and 80 mg/m\^2 of Paclitaxel IV on days 1 and 8 and Carboplatin IV on day 1), TURBT within 4-8 weeks of chemotherapy, option of proceeding with immediate cystectomy or observation.
    id
    FG000
    title
    Gemcitabine, Paclitaxel, Carboplatin Followed by Surgery
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Adverse Event
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Refusal unrelated to adverse event
    3. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Progression/relapse
    4. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Death
    5. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Ineligible
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        77
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        75
      type
      Eligible
    3. achievements
      1. group Id
        FG000
        num Subjects
        74
      type
      Eligible and Began Protocol Therapy
    4. achievements
      1. group Id
        FG000
        num Subjects
        71
      type
      COMPLETED
    5. achievements
      1. group Id
        FG000
        num Subjects
        6
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Patients receive 3 cycles (1 cycle = 21 days) of neoadjuvant chemotherapy (800 mg/m\^2 of gemcitabine IV and 80 mg/m\^2 of Paclitaxel IV on days 1 and 8 and Carboplatin IV on day 1), TURBT within 4-8 weeks of chemotherapy, option of proceeding with immediate cystectomy or observation.
    id
    FG000
    title
    Gemcitabine, Paclitaxel, Carboplatin Followed by Surgery
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Adverse Event
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Refusal unrelated to adverse event
    3. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Progression/relapse
    4. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Death
    5. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Ineligible
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        77
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        75
      type
      Eligible
    3. achievements
      1. group Id
        FG000
        num Subjects
        74
      type
      Eligible and Began Protocol Therapy
    4. achievements
      1. group Id
        FG000
        num Subjects
        71
      type
      COMPLETED
    5. achievements
      1. group Id
        FG000
        num Subjects
        6
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice